Company Overview of Chiasma (Israel) ltd.
Chiasma (Israel) ltd., a biopharmaceutical company, develops oral drugs based on transient permeability enhancer system. The company offers oral octreotide acetate for the treatment of acromegaly. Its pipeline products include novel drugs which addresses unmet needs for well-defined markets. The company focuses primarily on orphan indications. The company was founded in 2001 and is based in Jerusalem, Israel. Chiasma (Israel) ltd. operates as a subsidiary of Chiasma, Inc.
10 Hartom Street
Founded in 2001
972 2 571 5885
972 2 571 5886
Key Executives for Chiasma (Israel) ltd.
Chiasma (Israel) ltd. Key Developments
Similar Private Companies By Industry
|Tamarkin Pharmaceutical Innovation Ltd.||Middle East/Africa|
|Bio-Dar Ltd.||Middle East/Africa|
|LycoRed Ltd.||Middle East/Africa|
|Iluten Ltd.||Middle East/Africa|
|DermiPsor Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Chiasma (Israel) ltd., please visit www.chiasmapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.